阿司匹林-β-环糊精包合物PLGA微球的制备及其质量控制
x

请在关注微信后,向客服人员索取文件

篇名: 阿司匹林-β-环糊精包合物PLGA微球的制备及其质量控制
TITLE:
摘要: 目的:制备阿司匹林-β-环糊精包合物聚乳酸-羟基乙酸共聚物(PLGA)微球,并进行质量控制。方法:首先制备阿司匹林-β-环糊精包合物,再通过乳化溶剂挥发法制备阿司匹林-β-环糊精包合物PLGA微球,检测载药微球的形态和粒径,计算包封率和累积释放度。以包封率为指标,采用正交试验优化搅拌速度、聚乙烯醇(PVA)浓度、PVA体积、投料比。结果:最优处方工艺为搅拌速度4 000 r/min、PVA浓度3%(g/100 ml)、PVA体积30 ml、投药比1 ∶ 10。所制微球为圆球形,表面光滑,包封率为(41.79±1.09)%,粒径较为均一,粒径范围为0.5~127.5 μm;随着载药微球的降解,阿司匹林的释放速度较平缓,600 h内累积释放度为83%。结论:成功制得形态规则且具有缓释作用的阿司匹林-β-环糊精包合物PLGA微球。
ABSTRACT: OBJECTIVE: To prepare aspirin-β-cyclodextrin-PLGA microspheres, and control its quality. METHODS: Aspirin-β-cyclodextrin inclusion complexes were firstly prepared, and then aspirin-β-cyclodextrin-PLGA microspheres were prepared by emulsion-solvent evaporation method. The morphology and particle size of microspheres were detected, and entrapment efficiency and accumulative release rate were calculated. With entrapment efficiency as index, orthogonal test was adopted to optimize stirring speed, PVA concentration, PVA volume and feed ratio. RESULTS: The optimal formulation was as follows as stirring speed of 4 000 r/min, PVA concentration of 3% (g/100 ml), PVA volume of 30 ml, feed ratio of 1 ∶ 10. Prepared microspheres were round and smooth in appearance. Entrapment efficiency of the microspheres was (41.79±1.09)%. The diameter were regular and ranged 0.5-127.5 μm. As drug-loaded microspheres degraded, the release of aspirin was slow and its accumulative release rate was 83% within 600 h. CONCLUSIONS: Aspirin-β-cyclodextrin-PLGA microspheres are prepared successfully with regular morphology and good sustained-release.
期刊: 2016年第27卷第19期
作者: 卢建忠,刘婷婷,刘冬蕊,白璐,赵心洁,张诗晨,马宁
AUTHORS: LU Jianzhong,LIU Tingting,LIU Dongrui,BAI Lu,ZHAO Xinjie,ZHANG Shichen,MA Ning
关键字: 阿司匹林;β-环糊精;包合物;聚乳酸-羟基乙酸共聚物;微球;缓释
KEYWORDS: Aspirin; β-cyclodextrin; Inclusion complexes; PLGA; Microspheres; Sustained-release
阅读数: 300 次
本月下载数: 4 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!